NRG4 (Neuregulin-4) is a member of the neuregulin family of growth factors that signal through ErbB receptor tyrosine kinases. While the least characterized member of this family, NRG4 has emerged as an important regulator of energy metabolism, brown adipose tissue function, and potentially neuroprotection. NRG4 binds primarily to ErbB4 receptors and activates downstream signaling pathways that influence cell survival, differentiation, and metabolic homeostasis.
The neuregulin family comprises multiple isoforms (NRG1-NRG6) that play crucial roles in development, nervous system function, and disease. NRG4, despite being the least studied, has unique structural features and expression patterns that distinguish it from other neuregulins. It possesses a conserved EGF-like domain necessary for receptor binding but has distinct N-terminal regions that confer specificity for ErbB4 over other ErbB receptors.
| Property |
Value |
| Protein Name |
NRG4 (Neuregulin-4) |
| Gene |
NRG4 |
| UniProt ID |
Q8NFJ5 |
| Molecular Weight |
~50 kDa (full-length); ~20 kDa (mature secreted) |
| Subcellular Localization |
Plasma membrane, secreted |
| Protein Family |
Neuregulin family, EGF-like growth factors |
| Aliases |
Heregulin, Neuregulin-4, PRO2001 |
NRG4 protein exhibits several distinctive structural features:
- N-terminal region: Contains a unique domain that distinguishes NRG4 from other neuregulins and influences receptor binding specificity
- EGF-like domain: The conserved receptor-binding domain necessary for ErbB activation
- Transmembrane domain: Enables membrane-bound signaling in addition to secreted forms
- C-terminal tail: Variable region involved in protein-protein interactions
The protein can exist as either a membrane-bound precursor or a processed secreted form. Proteolytic cleavage releases the active EGF-like domain, which then binds to ErbB receptors on target cells.
NRG4 plays a crucial role in metabolic homeostasis:
- Brown adipose tissue (BAT): NRG4 is highly expressed in brown adipose tissue and regulates thermogenesis
- Energy expenditure: Promotes uncoupled respiration and heat production in brown adipocytes
- Insulin sensitivity: Improves glucose metabolism and insulin signaling
- Lipid metabolism: Regulates lipogenesis and lipolysis in adipose tissue
- Primary receptor: ErbB4 (HER4) is the main receptor for NRG4
- Receptor activation: Binding induces receptor dimerization and tyrosine phosphorylation
- Downstream pathways: Activates PI3K/Akt, MAPK/ERK, and STAT signaling
- Cell survival: Promotes cell survival through multiple anti-apoptotic mechanisms
Emerging evidence supports neuronal protective functions:
- Neuronal survival: NRG4 promotes survival of various neuronal populations
- Synaptic function: May influence synaptic plasticity and function
- Metabolic support: Could provide metabolic support to neurons through systemic effects
- Neuroinflammation: Modulates inflammatory responses in the nervous system
NRG4 exhibits several connections to Alzheimer's disease pathogenesis:
- Neuroprotective signaling: ErbB4 activation promotes neuronal survival and may protect against Aβ toxicity
- Metabolic dysfunction: NRG4 levels correlate with metabolic parameters altered in AD
- Synaptic plasticity: NRG4 signaling may support synaptic function impaired in AD
- Cholinergic neurons: Potential protection of basal forebrain cholinergic neurons vulnerable in AD
- Neuroinflammation: May modulate microglial activation and neuroinflammatory responses
- Dopaminergic neuron survival: NRG4 may protect dopaminergic neurons
- Metabolic regulation: Altered energy metabolism in PD may involve NRG4 dysregulation
- Neuroinflammation: Modulation of glial cell activation
The metabolic connections between NRG4 and neurodegeneration are increasingly recognized:
- Type 2 diabetes: Metabolic syndrome increases AD/PD risk; NRG4 improves insulin sensitivity
- Obesity: Alters NRG4 expression; obesity is an AD/PD risk factor
- Cardiovascular health: NRG4 affects vascular health relevant to vascular dementia
NRG4 represents a promising therapeutic target:
- Recombinant NRG4: Engineered NRG4 proteins could be developed for neuroprotection
- Small molecule agonists: Compounds that enhance NRG4 signaling
- Gene therapy: Viral vector-mediated NRG4 expression
- Metabolic targeting: NRG4-based therapies for metabolically-linked neurodegeneration
- Combination approaches: NRG4 with other neuroprotective strategies
NRG4 is relevant to the following neurodegenerative and related conditions:
- NRG4 in energy metabolism and disease, Trends Endocrinol Metab (2013)
- Neuregulin signaling pathways in disease, Cold Spring Harb Perspect Biol (2011)
- NRG4 and metabolic disease, J Mol Endocrinol (2018)
- ErbB4 signaling in neuroprotection, Neurobiol Dis (2019)